← Leaderboards
Brian H. Ladle
Johns Hopkins University
$1,546,152
Attributed
$3,092,303
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $637.4K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,092,303 · 1
By mechanism
R01$3,092,303 · 1
Top collaborators
- Dara L Kraitchman5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard Douglas Moore$80,558,192
- Joseph A Califano$16,242,638
- Stuart S Martin$11,571,187
- Dara L Kraitchman$14,405,090
- Neil R. Powe$19,036,767
Others in their field
Other Emerging Leaders on “Academic Medical Centers”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lisa Newman · Research Triangle Institute$22,725,934
- Craig Reist · Research Triangle Institute$22,725,934
- Scott Topper · Broad Institute, Inc.$20,157,828
- Molly Wasko · University Of Alabama At Birmingham$18,626,873
Research focus
Academic Medical CentersClientAdultAdaptive Immune ResponseAdaptive Immune SystemChildAnatomyAnimal HospitalsAnimal ModelAgonistAntigen-Presenting CellsAmino Acid SequenceAnti-Tumor Immune ResponseAmputationBiological ModelsBiotechnologyBoneBone NeoplasmsCancer TherapyCanis FamiliarisCell InjuryCellsChemotherapyClinically Relevant
Grant awards (5)
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$596,467
R01 · FY2024 · CA
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$615,301
R01 · FY2023 · CA
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$615,301
R01 · FY2022 · CA
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$627,858
R01 · FY2021 · CA
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$637,376
R01 · FY2020 · CA